ArticlePharmacoEconomics2024

Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.

Bradley M Sugden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.